Sam Agresta

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Anthony Stein, Robert Collins, Ross L Levine, 2017, Blood.

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Erica Hansen, Francesco G. Salituro, 2013, Science.

IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition.

Wei Liu, Fang Wang, Hua Yang, 2014, Blood.